Creo Medical Group PLC (AIM:CREO), an innovative UK-based medical technology company, recently showcased significant advancements during their Capital.
Creo Medical Group PLC (AIM:CREO) CEO Craig Gulliford speaks to Thomas Warner from Proactive after the minimally invasive electrosurgical device company.
Creo Medical Group PLC (AIM:CREO) has received clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device, paving the way.
Medical device company Creo Medical Group announced on Wednesday that it has received 510(k) clearance from the US Food and Drug Administration (FDA) for its Speedboat UltraSlim device.